Alteration of renin release by stress and adrenergic receptor and related drugs in unanesthetized rats.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000758:Anesthesia; D000804:Angiotensin II / Q000097:blood; D000818:Animals; D002714:Chlorisondamine / Q000494:pharmacology; D004039:Diet, Sodium-Restricted; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012083:Renin / Q000097:blood*; D013312:Stress, Physiological; D013550:Swimming; D014665:Vasodilator Agents / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D005730:Ganglionic Blockers; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II; D011433:Propranolol; D012083:Renin; D008729:Methoxamine; D010424:Pentobarbital; D002714:Chlorisondamine; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine